Last reviewed · How we verify
NCT04333446
Circulating Levels of Pealbumin in Relation to Overweight or Obesity
trial in Obesity in 84 participants. Completed in 31 December 2019.
26 July 2019
Quick facts
| Lead sponsor | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 84 |
| Start date | 7 January 2019 |
| Primary completion | 26 July 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Italy |
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Who can join
Eligibility, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study was aimed to investigating the relationship between circulating level of prealbumin and parathormone (PTH), triglycerides and triiodothyronine (FT3) in overweight and obese subjects (BMI≥25 Kg/m2)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04333446
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis trials
Trials by the same sponsor.
- NCT07497789 — SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases · not yet recruiting
- NCT07412444 — EVOO and Metabolic Liver Health in MASLD · NA · not yet recruiting
- NCT07153458 — Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer · recruiting
- NCT06931925 — Recall of a Cohort of Subjects in the Mediterranean Area. Monitoring of Liver Diseases (NUTRIHEP 3). · not yet recruiting
- NCT06830317 — Study on the Efficacy of Endoscopic Radiofrequency Treatment in Reducing the Need for Blood Transfusions in GAVE · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04333446 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- Last refreshed: 18 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04333446.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing